Cui and Yang found that benzo [a] pyrene (Bap) treatment repressed PTEN and FAK expression and activates PI3K/Akt signaling in patients with asthma, which is believed to contribute to the bronchial epithelial injury caused by Bap-mediated ROS generation and cell apoptosis. The gene discussed is PTK2; the disease is asthma.